Effects of angiotensin-converting enzyme inhibitor on plasma b-type natriuretic peptide levels in patients with acute myocardial infarction
- 1 December 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 3 (4) , 287-293
- https://doi.org/10.1016/s1071-9164(97)90028-2
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Sympathoinhibitory effects of atrial natriuretic factor in normal humans.Circulation, 1990
- C-Type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brainBiochemical and Biophysical Research Communications, 1990
- Intracerebroventricular injection of brain natriuretic peptide inhibits vasopressin secretion in conscious ratsNeuroscience Letters, 1988
- Antidipsogenic action of a novel peptide, ‘brain natriuretic peptide’, in ratsEuropean Journal of Pharmacology, 1988
- A new natriuretic peptide in porcine brainNature, 1988
- George E. Brown memorial lecture. Role of atrial peptides in body fluid homeostasis.Circulation Research, 1986
- Atriopeptin: A Cardiac Hormone Intimately Involved in Fluid, Electrolyte, and Blood-Pressure HomeostasisNew England Journal of Medicine, 1986
- Atrial Natriuretic Hormone, the Renin–Aldosterone Axis, and Blood Pressure–Electrolyte HomeostasisNew England Journal of Medicine, 1985
- Atrial Natriuretic Factor: A Hormone Produced by the HeartScience, 1985
- Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)Biochemical and Biophysical Research Communications, 1984